SAKINAH SHAW: Open Payments
NPI 1437856820 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,414 in 114 payments from 12 companies in 2025. Trend: 2023 $713 · 2024 $1,514 · 2025 $5,414
Speaker / faculty: $3,000Food & beverage: $2,042Education: $223Travel & lodging: $149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $3,566 |
| Supernus Pharmaceuticals, Inc. | 41 | $625 |
| Otsuka America Pharmaceutical, Inc. | 21 | $367 |
| Teva Pharmaceuticals USA, Inc. | 9 | $365 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $140 |
| E.R. Squibb & Sons, L.L.C. | 5 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Alkermes, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $34 |
| Indivior Inc. | 1 | $27 |
Products named: VRAYLAR, Qelbree, REXULTI, CAPLYTA, AUSTEDO XR, COBENFY, ABILIFY ASIMTUFII, HETLIOZ.
Industry payments across AR — which companies pay providers there.
